Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 20;44(9):1653-1661.
doi: 10.12122/j.issn.1673-4254.2024.09.04.

[Role of Abelson interactor 2 in progression and prognosis of gastric cancer and its regulatory mechanisms]

[Article in Chinese]
Affiliations

[Role of Abelson interactor 2 in progression and prognosis of gastric cancer and its regulatory mechanisms]

[Article in Chinese]
X Chen et al. Nan Fang Yi Ke Da Xue Xue Bao. .

Abstract

Objective: To explore the regulatory role of Abelson interactor 2 (ABI2) in progression and prognosis of gastric cancer.

Methods: TIMER2.0, GEPIA, Kaplan-Meier Plotter and DAVID databases were used to analyze ABI2 expression in pancancer and its association with the prognosis of gastric cancer. Gastric cancer and adjacent tissues from 120 patients undergoing radical gastrectomy in our hospital between January, 2016 and October, 2018 were examined for ABI2 expression and its correlation with disease progression and prognosis. MGC-803 cell models of ABI2 knockdown and overexpression were established for observing the changes in cell proliferation, migration, and invasion, and the impact of ABI2 expression modulation on xenograft growth was evaluated in nude mice.

Results: Database analysis and examination of the clinical samples showed that ABI2 was highly expressed in gastric cancer tissues. Survival analysis suggested that gastric cancer patients with a high expression of ABI2 had a reduced postoperative 5-year survival rate (P < 0.0001), and further Cox univariate and multivariate survival analyses indicated that a high ABI2 expression was an independent risk factor affecting the patients survival outcomes (P=0.022, HR=1.887, 95% CI: 1.096-3.249). Enrichment analysis suggested the involvement of ABI2 in Wnt signaling. In MGC-803 cells, ABI2 overexpression promoted cell proliferation and xenograft growth in nude mice, increased the expressions of vimentin and N-cadherin, and lowered E-cadherin expression, while ABI2 knockdown produced the opposite effects. Mechanistic analysis revealed that ABI2 overexpression promoted the expressions of Wnt2 and β-catenin in both MGC-803 cells and the xenografts, and their expressions were significantly lowered by ABI2 knockdown.

Conclusion: ABI2 is highly expressed in gastric cancer, which affects long-term prognosis of the patients, possible due to its regulatory effect on Wnt signaling to promote proliferation, migration and invasion of gastric cancer cells.

目的: 探讨Abelson相互作用因子2(ABI2)在胃癌进展和预后中的作用及机制。

方法: 通过TIMER2.0和GEPIA数据库分析ABI2在泛癌和胃癌中的表达,采用Kaplan-Meier Plotter数据库分析ABI2表达水平与胃癌预后的关系,通过DAVID数据库预测ABI2在生物系统中的功能。纳入在我院于2016年1月~2018年10月接受胃癌根治术治疗的120例胃癌患者,检测胃癌及癌旁组织中ABI2的表达水平,分析其与疾病进展的联系,并通过Cox单因素和多因素分析影响患者预后的危险因素。构建胃癌细胞系(MGC-803)ABI2干扰及过表达模型并构建裸鼠移植瘤模型,联合CCK-8、划痕、Transwell和免疫印迹实验分析ABI2对胃癌细胞增殖、迁移和侵袭的影响。结合体内外研究分析ABI2影响胃癌细胞恶性生物学行为的可能分子机理。

结果: 生信分析和本院胃癌组织检测结果表明ABI2在胃癌组织中高表达(P < 0.05)。Kaplan-Meier Plotter数据库分析表明ABI2低表达患者的术后生存率优于高表达患者(P < 0.0001)。本院患者的生存分析结果显示,胃癌组织中ABI2高表达患者术后5年生存率降低(P < 0.0001),Cox单因素和多因素生存分析进一步表明,ABI2高表达是影响胃癌患者预后的独立危险因素(P=0.022,HR=1.887,95% CI:1.096~3.249)。富集分析提示,ABI2的作用可能与Wnt信号通路相关。上调ABI2促进裸鼠移植瘤和胃癌细胞的增殖能力(P < 0.05),并增加Vimentin和N-cadherin的表达,同时降低E-cadherin的表达(P < 0.05);下调ABI2则相反(P < 0.05)。机制分析发现上调ABI2促进移植瘤组织和胃癌细胞中Wnt2和β-catenin的表达(P < 0.05),下调ABI2则相反(P < 0.05)。

结论: ABI2在胃癌中表达升高并影响疾病远期预后,其可能与调控Wnt信号通路进而促进胃癌细胞增殖、迁移和侵袭能力有关。

Keywords: ABI2; Wnt signaling pathway; gastric cancer; invasion; migration; prognosis; proliferation.

PubMed Disclaimer

Figures

图 1
图 1
ABI2在胃癌组织中表达水平升高 ABI2 is highly expressed in gastric cancer. A: Pan-cancer expression analysis. B: Expression of ABI2 in gastric and adjacent tissues. C, D: Immunohistochemical staining of ABI2 in gastric and adjacent tissues. *P < 0.05, **P < 0.01, ***P < 0.001.
图 2
图 2
胃癌组织中ABI2表达水平与外周血CEA和CA19-9水平呈正相关 ABI2 expression level in gastric cancer tissue is positively correlated with peripheral blood levels of CEA and CA19-9.
图 3
图 3
胃癌组织中ABI2表达水平影响胃癌患者预后 ABI2 expression level in gastric cancer tissues affects prognosis of the patients. A: ABI2 expression level affects overall survival of gastric cancer patients. B: Kaplan-Meier survival analysis of 5-year survival rate of the patients after radical gastrectomy.
图 4
图 4
胃癌组织中ABI2表达水平是胃癌患者的独立预后因素 ABI2 expression level in gastric cancer tissue is an independent prognostic factor for gastric cancer patients.
图 5
图 5
ABI2的KEGG和GO富集分析结果 Results of KEGG and GO enrichment analysis. A: KEGG enrichment analysis. B-D: Biological processes, cellular component and molecular function in GO enrichment analysis.
图 6
图 6
ABI2在体外实验中促进胃癌细胞增殖、迁移、侵袭和上皮间充质转化 ABI2 overexpression promotes proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT) of gastric cancer cells in vitro. A, B: Lentiviral transfection efficiency. C, D: Results of CCK-8 assay (presented as A values) from day 1 to day 5. E, F: Expression of EMT markers in MGC803 cells. G, H: Wound-healing assay of the cells. I-L: Migration and invasion of MGC803 cells. Si: siRNA; LV: overexpression. *P < 0.05 vs Control (n=3).
图 7
图 7
ABI2在体内实验中促进胃癌细胞增殖和上皮间充质转化 ABI2 overexpression promotes proliferation and epithelial-mesenchymal transition of gastric cancer cells in nude mice. A: Representative image of the transplanted tumors. B, C: Transplanted tumor volume from day 5 to day 25. D, E: Expression of EMT markers in the transplanted tumor. *P < 0.05 vs Control (n=3).
图 8
图 8
ABI2对胃癌细胞恶性生物学行为的影响可能与Wnt通路相关 The effect of ABI2 on malignant biological behaviors of gastric cancer cells is related to the Wnt signaling pathway. A, B: Expression of Wnt2 and β-catenin in MGC803 cells. C, D: Expression of Wnt2 and β-catenin in the transplanted tumors. *P < 0.05 vs Control (n=3).

References

    1. Smyth EC, Nilsson M, Grabsch HI, et al. Gastric cancer. Lancet. 2020;396(10251):635–48. doi: 10.1016/S0140-6736(20)31288-5. - DOI - PubMed
    1. 郑 荣寿, 张 思维, 孙 可欣, et al. 2016年中国恶性肿瘤流行情况分析. 中华肿瘤杂志. 2023;45(3):212–20. - PubMed
    1. Thrift AP, El-Serag HB. Burden of gastric cancer. Clin Gastroenterol Hepatol. 2020;18(3):534–42. doi: 10.1016/j.cgh.2019.07.045. - DOI - PMC - PubMed
    1. Chia NY, Tan P. Molecular classification of gastric cancer. Ann Oncol. 2016;27(5):763–9. doi: 10.1093/annonc/mdw040. - DOI - PubMed
    1. Jiang PX, Tang SN, Hudgins H, et al. The Abl/Abi signaling links WAVE regulatory complex to Cbl E3 ubiquitin ligase and is essential for breast cancer cell metastasis. Neoplasia. 2022;32:100819. doi: 10.1016/j.neo.2022.100819. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources